0 items USD 0.00Search
- Did you mean
- chronic lymphoma leukemia
Your search for "Chronic lymphocytic leukemia" gave back 4805 results.
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Acute lymphocytic/lymphoblastic leukemia (ALL) is a type of cancer that develops from immature lymphocytes. “Acute” here indicates leukemia that...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Afutuzumab, more commonly known as obinutuzumab is a humanized type II monoclonal antibody against CD20 (coded for by MS4A1 for the treatment of...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Bendamustine hydrochloride injection is a cytotoxic drug used to treat chronic lymphoblastic leukemia and non Hodgkin's lymphoma. The “...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Bruton’s tyrosine kinase (BTK) is a key component of the B-cell receptor (BCR) signalling pathway. BTK is an important protein that is a regulator of...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global BTK Inhibitor market size is expected to reach $ 1825.9 million by 2029, rising at a market growth of 10.4% CAGR during the forecast...
Catalog:
GIR
July 2023
Price: USD 4,480.00
The global BTK Inhibitor market size is projected to grow from US$ 866.7 million in 2022 to US$ 1834.6 million in 2029; it is expected to grow at a...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Bruton Tyrosine Kinase (BTK) Inhibitor market size is projected to grow from US$ 866.7 million in 2022 to US$ 1834.6 million in 2029; it...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The “Bendamustine Injection Industry Forecast” looks at past sales and reviews total world Bendamustine Injection sales in 2022, providing a...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
T-cell acute lymphoblastic leukemia (T-ALL) is a type of acute lymphoblastic leukemia, with features similar to lymphoma. It affects white blood...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global BTK Inhibitor market size was valued at USD 911.6 million in 2022 and is forecast to a readjusted size of USD 1825.9 million by 2029 with...
Catalog:
GIR
July 2023
Price: USD 3,480.00
The global Bruton Tyrosine Kinase (BTK) Inhibitor market size is expected to reach $ 1825.9 million by 2029, rising at a market growth of 10.4% CAGR...
Catalog:
GIR
July 2023
Price: USD 4,480.00
